Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2024 | The pitfalls in genomics for myeloid malignancies

Thomas Coats • 29 Apr 2024
BSH 2024
Acute Myeloid Leukemia Chronic Myeloid Leukemia General

Thomas Coats, PhD, Royal Devon University Hospital Foundation Trust, Exeter, UK, briefly summarizes a session on the pitfalls in genomics for myeloid malignancies. The emergence of novel digital support tools and technologies, such as RNA fusion panels, will aid clinicians in accurately diagnosing and risk-stratifying patients. This interview took place at the 64th Annual Scientific Meeting of the British Society for Haematology (BSH) Congress in Liverpool, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Thomas Coats

1:34
The future role of AI models in hematology and the need for high-quality data sets
Thomas Coats • 29 Apr 2024
1:17
Using an AI model to quantify under-utilization of alloSCT for AML in the UK
Thomas Coats • 29 Apr 2024

Related Videos

14:43
Current research into post-alloSCT maintenance therapy in AML
Ali Bazarbachi • 3 May 2024
4:09
Veno-occlusive disease as a post-transplant complication of HSCT
Mohamad Mohty • 17 Apr 2024
5:20
Targeted therapies in AML: menin, FLT3 and IDH inhibitors
Felicitas Thol • 19 Apr 2024
1:56
Addressing access inequality in CAR-T therapies
Francesca Del Bufalo • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals